BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10347337)

  • 1. Differential effects of enalapril and nitrendipine on the fibrinolytic system in essential hypertension.
    Sakata K; Shirotani M; Yoshida H; Urano T; Takada Y; Takada A
    Am Heart J; 1999 Jun; 137(6):1094-9. PubMed ID: 10347337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential hypertension.
    Sakata K; Shirotani M; Yoshida H; Kurata C
    J Am Coll Cardiol; 1998 Aug; 32(2):438-43. PubMed ID: 9708473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrendipine and enalapril combination therapy in mild to moderate hypertension: assessment of dose-response relationship by a clinical trial of factorial design.
    Roca-Cusachs A; Torres F; Horas M; Ríos J; Calvo G; Delgadillo J; Terán M;
    J Cardiovasc Pharmacol; 2001 Dec; 38(6):840-9. PubMed ID: 11707687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a long-term pharmacological interruption of the renin-angiotensin system on the fibrinolytic system in essential hypertension.
    Sakata K; Pawlak R; Urano T; Takada A
    Pathophysiol Haemost Thromb; 2002; 32(2):67-75. PubMed ID: 12214151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive drugs and fibrinolytic function.
    Fogari R; Zoppi A
    Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure.
    Goodfield NE; Newby DE; Ludlam CA; Flapan AD
    Circulation; 1999 Jun; 99(23):2983-5. PubMed ID: 10368114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of enalapril and nitrendipine on the excretion of epidermal growth factor and albumin in hypertensive NIDDM patients.
    Josefsberg Z; Ross SA; Lev-Ran A; Hwang DL
    Diabetes Care; 1995 May; 18(5):690-3. PubMed ID: 8586009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lisinopril, irbesartan, and amlodipine on the thrombogenic variables in the early and late stages of the treatment in hypertensive patients.
    Tiryaki O; Usalan C; Buyukhatipoglu H; Sayiner ZA; Kilisli H
    Clin Exp Hypertens; 2012; 34(2):145-52. PubMed ID: 21967026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed-dose combination enalapril/nitrendipine: a review of its use in mild-to-moderate hypertension.
    Siddiqui MA; Plosker GL
    Drugs; 2004; 64(10):1135-48. PubMed ID: 15139792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
    Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D
    Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isolated systolic hypertension threatens the heart and the brain. Fixed combination optimizes blood pressure control and offers clear prognostic advantage].
    MMW Fortschr Med; 2010 Sep; 152(34-35):50-1. PubMed ID: 20923030
    [No Abstract]   [Full Text] [Related]  

  • 12. Morbidity and mortality on combination versus monotherapy: a posthoc analysis of the Systolic Hypertension in Europe trial.
    Thijs L; Richart T; de Leeuw PW; Kuznetsova T; Grodzicki T; Kawecka-Jaszcz K; O'Brien E; Redón J; Birkenhäger WH; Fagard R; Staessen JA
    J Hypertens; 2010 Apr; 28(4):865-74. PubMed ID: 20051905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved fibrinolysis after one year of treatment with enalapril in men and women with uncomplicated myocardial infarction.
    Boman KO; Jansson JH; Nyhlén KA; Nilsson TK
    Thromb Haemost; 2002 Feb; 87(2):311-6. PubMed ID: 11859853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of combined angiotensin-converting enzyme and aldosterone inhibition on plasma plasminogen activator inhibitor type 1 levels in chronic hypertensive patients.
    Tiryaki O; Usalan C; Buyukhatipoglu H
    Nephrology (Carlton); 2010 Mar; 15(2):211-5. PubMed ID: 20470281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nitrendipine and enalapril on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension.
    Gerritsen TA; Bak AA; Stolk RP; Jonker JJ; Grobbee DE
    J Hypertens; 1998 May; 16(5):689-96. PubMed ID: 9797181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effect of the calcium channel blocker nitrendipine on nephrosclerosis in rats with renovascular hypertension.
    Wenzel UO; Troschau G; Schoeppe W; Helmchen U; Schwietzer G
    Hypertension; 1992 Aug; 20(2):233-41. PubMed ID: 1639466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives.
    Weir MR; Chrysant SG; McCarron DA; Canossa-Terris M; Cohen JD; Gunter PA; Lewin AJ; Mennella RF; Kirkegaard LW; Hamilton JH; Weinberger MH; Weder AB
    Hypertension; 1998 May; 31(5):1088-96. PubMed ID: 9576119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dynamic comparative study concerning the effects of angiotensin-converting enzyme inhibitors and aldosterone receptor blockers on the fibrinolytic system.
    Usalan C; Buyukhatipoglu H
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):203-9. PubMed ID: 18372278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
    J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.